Page last updated: 2024-09-03

2'-cyano-2'-deoxyarabinofuranosylcytosine and Experimental Neoplasms

2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, Y; Sasaki, T; Zhang, M1
Hanaoka, K; Hisaoka, M; Ikeda, T; Iwabuchi, H; Kaneko, M; Kobayashi, T; Kurakata, S; Matsuda, A; Mitsuhashi, Y; Miura, S; Nakagawa, A; Nomura, T; Sasaki, T; Shibayama, T; Suzuki, M; Tanaka, K; Tanzawa, F; Tomida, A; Tsuruo, T; Wataya, Y1
Asai, T; Kondo, M; Kuromi, K; Matsuda, A; Ogino, K; Oku, N; Shimizu, K; Shuto, S; Taki, T; Watanabe, K1

Other Studies

3 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and Experimental Neoplasms

ArticleYear
Determinants in chemosensitivity of oncogene-transformed NIH3T3 cells to 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine.
    International journal of oncology, 1999, Volume: 14, Issue:3

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Division; Cell Transformation, Neoplastic; Chick Embryo; Cytarabine; Cytidine Deaminase; Deoxycytidine Kinase; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Oncogenes; Transformation, Genetic; Tritium

1999
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
    International journal of cancer, 1999, Jul-19, Volume: 82, Issue:2

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformation; Breast Neoplasms; Cisplatin; Cytarabine; Cytosine; Deoxycytidine; Deoxycytidine Kinase; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; KB Cells; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Mitomycin; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Nude; Specific Pathogen-Free Organisms; Stomach Neoplasms; Tumor Cells, Cultured; Vincristine

1999
Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.
    FEBS letters, 2002, Jun-05, Volume: 520, Issue:1-3

    Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cytarabine; Drug Delivery Systems; Liposomes; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Oligopeptides; Phosphatidic Acids; Survival Analysis; Time Factors; Tissue Distribution; Treatment Outcome; Tumor Cells, Cultured

2002